Risk-based treatment for nonrhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients under 30 years of age: Children’s Oncology Group study ARST0332.Sheri L. Spunt, Alberto S. Pappo, Beth McCarville et al.|Journal of Clinical Oncology|2014Cited by 30
Risk-based treatment for synovial sarcoma in patients under 30 years of age: Children’s Oncology Group study ARST0332.Rajkumar Venkatramani, Sheri L. Spunt, Lynn Million et al.|Journal of Clinical Oncology|2015Cited by 2